(Q45240483)

11 December 2017

Minocycline protects against permanent cerebral ischemia in wild type but not in matrix metalloprotease-9-deficient mice (English)

1 reference

11 December 2017

1 reference

1 reference

3

1 reference

11 December 2017

7

1 reference

11 December 2017

Milla Koistinaho

1

1 reference

11 December 2017

Tarja M Malm

2

1 reference

11 December 2017

Gundars Goldsteins

4

1 reference

11 December 2017

Sofie Starckx

5

1 reference

11 December 2017

Risto A Kauppinen

6

1 reference

11 December 2017

Jari Koistinaho

8

1 reference

11 December 2017

1 April 2005

1 reference

Journal of Cerebral Blood Flow & Metabolism

11 December 2017

1 reference

11 December 2017

25

1 reference

11 December 2017

4

1 reference

11 December 2017

460-467

1 reference

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

11 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Inflammatory mediators and stroke: new opportunities for novel therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Cerebral microvessel responses to focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Focal cerebral ischemia induces active proteases that degrade microvascular matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Differences in vulnerability to permanent focal cerebral ischemia among 3 common mouse strains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Neutralizing antibodies in gene-defective hosts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Proteolytic cascade enzymes increase in focal cerebral ischemia in rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Treatment of epigallocatechin-3-gallate inhibits matrix metalloproteinases-2 and -9 via inhibition of activation of mitogen-activated protein kinases, c-jun and NF-kappaB in human prostate carcinoma DU-145 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Effects of minocycline alone and in combination with mild hypothermia in embolic stroke

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600040

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600040

1 reference

11 December 2017

1 reference